Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | HPGD | P15428 | 3/20 | 0.38 |
| ▸ | TTR | P02766 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.38 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.38 |
| ▸ | HTR1A | P08908 | 1/20 | 0.38 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.38 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2176042 | 0.85 | KDM4E (0.50) | ALDH1A1KMT2AMAPTHPGDTTR | |
| SCHEMBL29117714 | 0.79 | ELANE (0.45) | ELANEALDH1A1KMT2AMAPTHPGD | |
| SCHEMBL8622400 | 0.78 | TTR (0.56) | ELANEALDH1A1KMT2AMAPTHPGD | |
| SCHEMBL6662940 | 0.78 | TOP1 (0.60) | ELANEALDH1A1KMT2AMAPTHPGD | |
| SCHEMBL27957751 | 0.78 | POLM (0.46) | ELANEALDH1A1KMT2AMAPTHPGD | |
| SCHEMBL29445347 | 0.78 | TYMS (0.57) | ELANEALDH1A1KMT2AMAPTHPGD | |
| SCHEMBL966421 | 0.78 | TYMS (0.57) | ELANEALDH1A1KMT2AMAPTHPGD | |
| SCHEMBL9663235 | 0.78 | TDP1 (0.44) | ELANEALDH1A1KMT2AMAPTHPGD | |
| SCHEMBL28633753 | 0.77 | KDM4E (0.50) | ELANEALDH1A1KMT2AMAPTHPGD | |
| SCHEMBL17460659 | 0.76 | MAOA (0.56) | ELANEALDH1A1KMT2AMAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11111320-B2 | Addition-fragmentation oligomers | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2021-09-07 | — | — | US | disclosed |
| EP-3326711-B1 | GRAFT COPOLYMER FUNCTIONALIZED ARTICLE | 3M INNOVATIVE PROPERTIES CO (US) | 2021-07-07 | — | — | EP | disclosed |
| EP-2675783-B1 | ADDITION-FRAGMENTATION AGENTS | 3M INNOVATIVE PROPERTIES CO (US) | 2020-04-22 | — | — | EP | disclosed |
| EP-3259323-B1 | ADDITION-FRAGMENTATION OLIGOMERS | 3M INNOVATIVE PROPERTIES CO (US) | 2020-02-26 | — | — | EP | disclosed |
| US-20200031961-A1 | ADDITION-FRAGMENTATION OLIGOMERS | 3M INNOVATIVE PROPERTIES CO (US) | 2020-01-30 | — | — | US | disclosed |
| US-10479848-B2 | Addition-fragmentation oligomers | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2019-11-19 | — | — | US | disclosed |
| US-10471398-B2 | Graft copolymer functionalized article | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2019-11-12 | — | — | US | disclosed |
| US-10370322-B2 | Addition-fragmentation agents | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2019-08-06 | — | — | US | disclosed |
| EP-3502092-A1 | ADDITION-FRAGMENTATION AGENTS | 3M Innovative Properties Company (US) | 2019-06-26 | — | — | EP | disclosed |
| US-10144760-B2 | Ligand functional substrates | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2018-12-04 | — | — | US | disclosed |
| WO-2014099317-A1 | ADDITION-FRAGMENTATION OLIGOMERS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2014-06-26 | — | — | WO | disclosed |
| EP-2691772-A1 | LIGAND FUNCTIONAL SUBSTRATES | 3M Innovative Properties Company (US) | 2014-02-05 | — | — | EP | disclosed |
| EP-2675783-A1 | ADDITION-FRAGMENTATION AGENTS | 3M Innovative Properties Company (US) | 2013-12-25 | — | — | EP | disclosed |
| WO-2013184366-A1 | GRAFT COPOLYMER FUNCTIONALIZED ARTICLE | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2013-12-12 | — | — | WO | disclosed |
| WO-2013151739-A1 | CROSSLINKABLE COMPOSITION COMPRISING PHOTOBASE GENERATORS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2013-10-10 | — | — | WO | disclosed |
| WO-2013028401-A1 | ADDITION-FRAGMENTATION AGENTS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2013-02-28 | — | — | WO | disclosed |
| US-20120252091-A1 | LIGAND FUNCTIONAL SUBSTRATES | 3M INNOVATIVE PROPERTIES COMPANY | 2012-10-04 | — | — | US | disclosed |
| WO-2012134636-A1 | LIGAND FUNCTIONAL SUBSTRATES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2012-10-04 | — | — | WO | disclosed |
| WO-2012112304-A1 | ADDITION-FRAGMENTATION AGENTS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2012-08-23 | — | — | WO | disclosed |
| US-20120208965-A1 | ADDITION-FRAGMENTATION AGENTS | 3M INNOVATIVE PROPERTIES COMPANY | 2012-08-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10479848-B2 | Addition-fragmentation oligomers | ECPAS, ITGA8, NBAS | ELANE 2991/4885ALDH1A1 2212/4885KMT2A 2118/4885 |
| US-10144760-B2 | Ligand functional substrates | PCNA, POLM, POLL | ELANE 1666/4885ALDH1A1 4565/4885KMT2A 3710/4885 |
| US-10370322-B2 | Addition-fragmentation agents | NR4A1, PARP14, MTX1 | ELANE 748/4885ALDH1A1 3630/4885KMT2A 2178/4885 |
| US-20200031961-A1 | ADDITION-FRAGMENTATION OLIGOMERS | ECPAS, ITGA8, NBAS | ELANE 2991/4885ALDH1A1 2212/4885KMT2A 2118/4885 |
| US-11111320-B2 | Addition-fragmentation oligomers | ECPAS, ITGA8, NBAS | ELANE 2991/4885ALDH1A1 2212/4885KMT2A 2118/4885 |
| US-20120252091-A1 | LIGAND FUNCTIONAL SUBSTRATES | PCNA, POLM, POLL | ELANE 1666/4885ALDH1A1 4565/4885KMT2A 3710/4885 |
| US-20120208965-A1 | ADDITION-FRAGMENTATION AGENTS | NR4A1, PARP14, MTX1 | ELANE 748/4885ALDH1A1 3630/4885KMT2A 2178/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.